Company Details
Global Cord Blood Corporation
48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
Overview
China Cord Blood Corporation operates umbilical cord blood banking services in China. The company’s core product is the collection and storage of umbilical cord blood. Global investment firm Kohlberg Kravis Roberts & Co. (KKR) has agreed to invest US$65 million in the company. The investment will be made through the KKR China Growth Fund. KKR said the funds will be used in part to support the company’s business expansion. The transaction represents KKR’s first investment in the healthcare services industry in China.
- Total raised
- $65M
- Funding rounds
- 1
- Latest round
- Equity
- Latest activity
- Apr 2012
Industries
- Biotechnology
- Health Care
- Hospital
- Life Science
- Medical
Recent funding
Equity
Apr 2012
$65M
Team
No current team members are available.